-
61
Repression of PFKFB3 sensitizes ovarian cancer to PARP inhibitors by impairing homologous recombination repair
Published 2025-01-01Subjects: “…Ovarian cancer…”
Get full text
Article -
62
Perspectives of pressurized intraperitoneal aerosol chemotherapy in terms of primary ovarian cancer with peritoneal carcinomatosis treatment
Published 2023-03-01Subjects: “…ovarian cancer…”
Get full text
Article -
63
-
64
Burkitt’s Lymphoma Presented as Advanced Ovarian Cancer without Evidence of Lymphadenopathy: CT and MRI Findings
Published 2013-01-01“…We present a case of a 23-year-old woman with sporadic Burkitt’s lymphoma presented as advanced ovarian cancer with bilateral ovarian masses, peritoneal carcinomatosis, ascites, and marked elevation of CA-125. …”
Get full text
Article -
65
Integrated microRNA and mRNA signatures associated with overall survival in epithelial ovarian cancer.
Published 2021-01-01“…Ovarian cancer (OC), the eighth-leading cause of cancer-related death among females worldwide, is mainly represented by epithelial OC (EOC) that can be further subdivided into four subtypes: serous (75%), endometrioid (10%), clear cell (10%), and mucinous (3%). …”
Get full text
Article -
66
Exploiting Cancer Dormancy Signaling Mechanisms in Epithelial Ovarian Cancer Through Spheroid and Organoid Analysis
Published 2025-01-01Subjects: “…epithelial ovarian cancer…”
Get full text
Article -
67
Sempervirine inhibits proliferation, invasion and metastasis of ovarian cancer cells and induces ultrastructural changes in vivo
Published 2025-01-01“…Abstract Ovarian cancer is one of the deadliest gynecological malignancies due to its late diagnosis and easy recurrence. …”
Get full text
Article -
68
-
69
Adjuvant Chemotherapy in Patients with Low-Risk Epithelial Ovarian Cancer: A Taiwanese Cohort Study
Published 2023-04-01Subjects: Get full text
Article -
70
Case report: A panorama gene profile of ovarian cancer metastasized to axillary lymph node
Published 2025-01-01Subjects: “…ovarian cancer…”
Get full text
Article -
71
Identification of Hypoxia Signature to Assess the Tumor Immune Microenvironment and Predict Prognosis in Patients with Ovarian Cancer
Published 2021-01-01“…The 5-year overall survival rate of ovarian cancer (OC) patients is less than 40%. Hypoxia promotes the proliferation of OC cells and leads to the decline of cell immunity. …”
Get full text
Article -
72
Acute heart failure following platinum and taxane-based chemotherapy for high grade ovarian cancer
Published 2025-02-01Get full text
Article -
73
A new strategy for the treatment of advanced ovarian cancer: utilizing nanotechnology to regulate the tumor microenvironment
Published 2025-02-01Subjects: “…advanced ovarian cancer (AOC)…”
Get full text
Article -
74
Advances in small extracellular vesicles: roles in the tumor microenvironment and epithelial ovarian cancer diagnosis and treatment
Published 2025-02-01Subjects: Get full text
Article -
75
Transcriptome analysis of ovarian cancer uncovers association between tumor-related inflammation/immunity and patient outcome
Published 2025-02-01Subjects: “…epithelial ovarian cancer…”
Get full text
Article -
76
RETRACTED: Modern Subtype Classification and Outlier Detection Using the Attention Embedder to Transform Ovarian Cancer Diagnosis
Published 2024-01-01Subjects: “…ovarian cancer…”
Get full text
Article -
77
Network of Mediators for Vascular Inflammation and Leakage Is Dysbalanced during Cytoreductive Surgery for Late-Stage Ovarian Cancer
Published 2019-01-01“…Cytoreductive surgery (CS) in late-stage ovarian cancer patients is often challenging due to extensive volume shifts, and high fluid intake may provoke postoperative complications. …”
Get full text
Article -
78
Downregulation of RIPK4 Expression Inhibits Epithelial-Mesenchymal Transition in Ovarian Cancer through IL-6
Published 2021-01-01“…RIPK4 has been implicated in multiple cancer types, but its role in ovarian cancer (OC) has not been clearly elucidated. Our data from Gene Expression Profiling Interactive Analysis, RT-PCR, and immunohistochemical analysis showed that RIPK4 was expressed at higher levels in OC tissues and cells than in normal ovarian tissues and cells. …”
Get full text
Article -
79
Comparison of clinico-pathological characteristics and survival of recurrent ovarian cancer patients on seven different chemo-protocols
Published 2019-03-01Subjects: “…ovarian cancer…”
Get full text
Article -
80
Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis
Published 2024-11-01Subjects: Get full text
Article